- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
FDA Warns MS Patients About Risky Treatment
U.S. drug regulators are warning people with multiple sclerosis that an experimental treatment that props open internal veins in the neck and chest can cause death or serious injury.
The Food and Drug Administration on Thursday said at least two people had died from the procedure, which uses stents or balloon angioplasties to widen veins that connect the brain and spinal cord to the heart. One person was permanently paralyzed, and others had bleeding in the brain, suffered strokes, blood clots or other side effects.
Read the full story:
Source: Reuters
Vertical Integration in Cardiology Brings Less Value, Analysis Finds
November 25th 2024The health care policy poster session, “Behind the Curtain: How Healthcare Policy Shapes Patient Outcomes,” took place Monday, November 18, 2024, the final day of the American Heart Association Scientific Sessions.
Read More
Real-World Challenges in DMD PMO Treatment
November 25th 2024A claims-based study revealed high adherence to phosphorodiamidate morpholino oligomer (PMO) treatments for Duchenne muscular dystrophy (DMD), but highlights limitations in interpreting real-world effectiveness from claims data.
Read More
Women Experiencing Partner Violence More Motivated to Receive PrEP
November 25th 2024Women with higher symptoms of post-traumatic stress disorder and major depressive disorder after intimate partner violence were more likely to have higher motivation to receive pre-exposure prophylaxis (PrEP).
Read More
